AARON R BLOCK

Allopathic & Osteopathic Physicians|Family Medicine CASTLE ROCK, CO NPI 1437578762

General Payments — all program years on this page

$16,756.81

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 361
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $878.31 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $878.3115

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $328.124
Acerta Pharma LLC $190.954
ViiV Healthcare Company $164.603
ABIOMED $117.021
Lucid Diagnostics Inc. $37.381
PFIZER INC. $22.891
Exeltis, USA Inc. $17.351

By program year

Program yearAmountRecords
2018 $1,963.2389
2019 $4,311.17102
2020 $5,274.8176
2021 $3,965.2469
2022 $364.0510
2024 $878.3115

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104636981 AstraZeneca Pharmaceuticals LP $20.85 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105281295 AstraZeneca Pharmaceuticals LP $35.86 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105579428 AstraZeneca Pharmaceuticals LP $13.35 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105641098 AstraZeneca Pharmaceuticals LP $120.89 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111531668 Amgen Inc. $31.39 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111531670 Amgen Inc. $120.89 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112714412 ViiV Healthcare Company $19.53 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112739907 ViiV Healthcare Company $123.12 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112745447 ViiV Healthcare Company $21.95 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117509356 Amgen Inc. $31.80 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117509358 Amgen Inc. $144.04 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131841910 PFIZER INC. $22.89 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142200487 ABIOMED $117.02 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149987477 Exeltis, USA Inc. $17.35 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152300864 Lucid Diagnostics Inc. $37.38 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.